[Form 4] Core Scientific, Inc. Tranche 2 Warrants Insider Trading Activity

Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) – Form 4 insider filing

Chief Legal & Administrative Officer Todd M. DuChene reported an automatic share disposition on 01 July 2025 related to the vesting of restricted stock units (RSUs). The disposition is coded “F,” indicating shares were withheld by the company to cover federal and state tax obligations, not an open-market sale.

• Shares withheld (Code F): 8,228 common shares at an implied price of $17.07.
• Post-transaction direct ownership: 2,041,461 common shares.
• No derivative securities were reported in this filing.

The transaction is administrative and does not reflect a change in Mr. DuChene’s investment intent. Insider still holds a sizable equity position, suggesting continued alignment with shareholders. There are no indications of open-market selling pressure or material corporate developments within this filing.

Insights

Corporate Governance Analyst

TL;DR – Routine tax-withholding; neutral to CORZ valuation.

Code F transactions merely satisfy payroll tax on equity awards. No cash proceeds change hands and the insider’s net economic exposure remains essentially unchanged. The officer retains over 2.0 million shares, signalling long-term alignment. Such filings are standard housekeeping and rarely move the stock. Absent additional sales, the event is non-impactful for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUCHENE TODD M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DE 19904

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		F(1)		8,228	D	$17.07	2,041,461	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Remarks:

Chief Legal and Administrative Officer

	/s/ Todd DuChene	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Core Scientific (CORZ) shares did Todd DuChene dispose of on 01-Jul-2025?

The filing shows 8,228 common shares were withheld to cover taxes.

What is transaction code "F" in a Form 4?

Code F denotes payment of tax or exercise price through share withholding, not an open-market sale.

How many CORZ shares does the officer own after the transaction?

Todd DuChene directly owns 2,041,461 common shares following the RSU vesting.

Does this Form 4 indicate insider selling pressure at Core Scientific?

No. Shares were withheld for taxes; no discretionary sale took place.

Were any derivative securities (options, warrants) involved?

No derivative transactions were reported in this filing.